Clinical Trial Update: Eszopiclone for Improving Sleep in Multiple Sclerosis (MS) [NA]

View source ↗

Summary

Clinical trial update shows completion of a study evaluating eszopiclone for improving sleep in patients with Relapsing Remitting Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis
• Sleep Initiation and Maintenance Disorders

Drugs mentioned

• Lunesta (eszopiclone)

Snippet

Sponsor: University of Vermont | Conditions: Relapsing Remitting Multiple Sclerosis, Sleep Initiation and Maintenance Disorders | NA | Status: COMPLETED